UGT1A1 genotype as an indicator of neutropenia for FOLFOXIRI with bevacizumab in patients with mCRC (QUATTRO study)

被引：0
|
作者：
Oki, Eiji [1 ]
Yoshino, Takayuki [2 ]
Muro, Kei [3 ]
Emi, Yasunori [4 ]
Tsuji, Akihito [5 ]
Yamasaki, Kentaro [10 ]
Yamanaka, Takeharu [7 ]
Sakisaka, Hideki [6 ]
Kato, Takeshi [8 ]
Kanazawa, Akiyoshi [9 ]
机构：
[1] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka, Japan
[2] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan
[3] Aichi Canc Ctr Hosp, Nagoya, Aichi, Japan
[4] Saiseikai Fukuoka Gen Hosp, Fukuoka, Japan
[5] Kagawa Univ, Takamatsu, Kagawa, Japan
[6] Osaka Minato Cent Hosp, Osaka, Japan
[7] Yokohama City Univ, Yokohama, Kanagawa, Japan
[8] Kansai Rosai Hosp, Amagasaki, Hyogo, Japan
[9] Kitano Hosp, Osaka, Japan
[10] Shizuoka Canc Ctr, Nagaizumi, Shizuoka, Japan
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ISY-17-2
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Analysis of the UGT1A1 Genotype in Hyperbilirubinemia Patients: Differences in Allele Frequency and Distribution
    Mi, Xiao-xiao
    Yan, Jian
    Ma, Xiao-jie
    Zhu, Ge-li
    Gao, Yi-dan
    Yang, Wen-jun
    Kong, Xiao-wen
    Chen, Gong-ying
    Shi, Jun-ping
    Gong, Ling
    BIOMED RESEARCH INTERNATIONAL, 2019, 2019
  • [22] Clinical implications of UGT1A1☆28 genotype testing in colorectal cancer patients
    Shulman, Katerina
    Cohen, Ilana
    Barnett-Griness, Ofra
    Gruber, Stephen B.
    Lejbkowicz, Flavio
    Rennert, Gad
    CANCER RESEARCH, 2010, 70
  • [23] The impact of UGT1A1*28 and UGT1A1*6 on irinotecan-induced neutropenia in Asian cancer patients receiving weekly and three weekly irinotecan regimens
    Chowbay, B.
    Rao, S. J. Srinivasa Jada
    Cher, B. C. Goh Boon
    Lim, R. Robert
    Teck, W. T. Lim Wan
    Huat, E. H. Tan Eng
    EJC SUPPLEMENTS, 2006, 4 (12): : 136 - 136
  • [24] A homozygous UGT1A1*28 genotype appears to predict grade 3−4 treatment-induced neutropenia in patients receiving irinotecan,
    Reactions Weekly, 2010, 1292 (1) : 3 - 3
  • [25] Evaluation of the role of UGT1A1 genotype testing in colorectal cancer patients administered irinotecan and the occurence of grade 3 and 4 neutropenia.
    Patel, Sushma M.
    Chan, Jim
    Hui, Rita L.
    Spence, Michele M.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [26] UGT1A1 and BLVRA allele and genotype variants in neonatal patients with hyperbilirubinemia in southern China
    Liu, XiuJu
    Zhang, Chao
    Chen, LiWen
    Liu, ShuYan
    Zhou, ZhenWen
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [27] UGT1A1 promoter genotype is not associated with coronary artery disease
    Papez, M. J.
    Civalier, C.
    Thorne, L. B.
    Gulley, M. L.
    MODERN PATHOLOGY, 2008, 21 : 65A - 65A
  • [28] UGT1A1*28 GENOTYPE AFFECTS THE IN VITRO GLUCURONIDATION OF BISPHENOL A
    Trdan, T.
    Roskar, R.
    Trontelj, J.
    Mrhar, A.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 44 : 193 - 194
  • [29] UGT1A1 promoter genotype is not associated with coronary artery disease
    Papez, N. J.
    Civalier, C.
    Thorne, L. B.
    Gulley, M. L.
    LABORATORY INVESTIGATION, 2008, 88 : 65A - 65A
  • [30] UGT1A1 genotype appears useful for predicting irinotecan toxicity
    Reactions Weekly, 2004, 995 (1) : 4 - 4
12345